Table A4.
Differentially expressed metabolites of all breast cancer patients and of the luminal B subgroup compared to the metabolic profiles already published in the literature.
| Author | Overlapping Metabolites (All Breast Cancer Patients) |
Non-Overlapping Metabolites Published |
|---|---|---|
|
Dìaz-Béltran et al.
(blood plasma) |
0 | LyoPC a C14:0 LysoPC a C16:0 LysoPC a C23:0 Biliverdin |
|
Ide et al., 2013
Uchiyama et al., 2014 Hosokawa et al., 2017 (tissue) |
PC aa C38:5 | PC aa C36:1 PCaa C34:1 PC aa C38:6 PC aa C32:1 PC aa C34:0 PC aa C30:0 |
| Author |
Overlapping metabolites (luminal B patients) |
Non-overlapping metabolites published |
|
Dìaz-Béltran et al.
(blood plasma) |
LysoPC a C16:0 | LyoPC a C14:0 LysoPC a C23:0 Biliverdin |
|
Ide et al., 2013
Uchiyama et al., 2014 Hosokawa et al., 2017 (tissue) |
PC aa C32:1 | PC aa C38:6 PC aa C34:0 PC aa C30:0 PC aa C38:5 PC aa C36:1 PC aa C34:1 |